Ultralife Corporation
NASDAQ:ULBIElectrical Equipment & Parts
+$0.08 today
- Market cap
- $261.13M
- Beta
- 0.76
- P/E (TTM)
- -12.9
- EPS (TTM)
- -$0.49
Volume 0.10M
Average 0.05M
ULBI Common Stock Issued
Cash raised by issuing new shares.
Ultralife CorporationNASDAQ: ULBI
Common Stock Issued · Q1 FY2026 · quarter ended Mar 2026
Common stock issued outflow grows to $0
Q1 FY2026 common stock issued was $0, compared with $0 a year earlier. Trailing-twelve-month common stock issued was $98K. Over 3 fiscal years it compounded at -5.5% a year.
Context
- Common stock issued amounted to 0.1% of revenue in FY2025, down 1.2 pp from a year earlier.
- Common stock issued increased in 2 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly common stock issued holds near $0 or moves back toward the trailing-twelve-month quarterly average of $24.5K.
Sources:Cash FlowText generated from reported figures; not investment advice.
Common Stock Issued history
USD · from the cash flow
- Latest · FY2025
- 98K USD
- Year-over-year change
- -95.1%
- 4-year CAGR
- -29.6%
| Period | Period end | Common Stock Issued | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 98K | -95.1% |
| FY2024 | 2024-12-31 | 2M | +60.2% |
| FY2023 | 2023-12-31 | 1.25M | +975.9% |
| FY2022 | 2022-12-31 | 116K | -70.9% |
| FY2021 | 2021-12-31 | 398K | — |
Common Stock Issued vs competitors
How ULBI compares with its peers on the latest reported figures
- ULBI's LTM Mar 2026 common stock issued of $98K is the 5th largest of the 7 companies compared; the peer median is $4.64M.
- Its year-over-year change of -92.5% is the lowest of 5, against a peer median of +235.6%.
- Common stock issued amounts to 0.1% of revenue for ULBI, versus a peer median of 7.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $21.24M | +354.9% | +162.4% | 1293.3% | |
| FY2026 | $12M | +433.3% | +53.8% | — | |
| LTM Jan 2026 | $6.03M | -69.5% | +537.8% | 175.4% | |
| LTM Mar 2026 | $3.25M | +116.2% | — | 7.7% | |
| LTM Mar 2026 | $98K | -92.5% | -5.5% | 0.1% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding ULBI) | $4.64M | +235.6% | +162.4% | 7.7% | |
Competitors are the stored peer set for ULBI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (230K) | (120K) | 7.2M | 6.41M | (5.9M) |
| Depreciation & Amortization | 3.54M | 4.46M | 3.91M | 4.16M | 5.5M |
| Deferred Income Tax | (147K) | (962K) | 1.3M | 1.23M | (2.54M) |
| Stock-Based Compensation | 671K | 776K | 528K | 698K | 935K |
| Change in Working Capital | 388K | (5.45M) | (11.04M) | 3.89M | 602K |
| Accounts Receivables | 4.42M | (7.88M) | (3.89M) | 7.6M | (4.35M) |
| Inventory | (1.3M) | (8.75M) | (943K) | (109K) | (2.35M) |
| Accounts Payables | (2.71M) | 10.09M | (2.97M) | 215K | 5.78M |
| Other Working Capital | (27K) | 1.09M | (3.24M) | (3.82M) | 1.52M |
| Other Non-Cash Items | 104K | 36K | 33K | 253K | 12.39M |
| Operating Cash Flow | 4.33M | (1.26M) | 1.93M | 16.64M | 10.99M |
| Capital Expenditures | (2.81M) | (1.68M) | (2.55M) | (1.93M) | (3.87M) |
| Acquisitions (Net) | (23.52M) | 0 | 0 | (48.02M) | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (26.33M) | (1.68M) | (2.55M) | (49.95M) | (3.87M) |
| Debt Repayment | 19.51M | 517K | 4.25M | 29.25M | (4.75M) |
| Common Stock Issued | 398K | 116K | 1.25M | 2M | 98K |
| Common Stock Repurchased | (148K) | (15K) | (8K) | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (262K) | (115K) | 1.25M | (1.39M) | (24K) |
| Financing Cash Flow | 19.64M | 518K | 5.49M | 29.86M | (4.68M) |
| Effect of Forex Changes | 126K | (276K) | (302K) | 34K | 49K |
| Net Change in Cash | (2.24M) | (2.7M) | 4.57M | (3.42M) | 2.49M |
| Free Cash Flow | 1.51M | (2.94M) | (623K) | 14.7M | 7.12M |
Ultralife Corporation
NASDAQ:ULBI
Intrinsic Alpha fair value
Locked
Current Price
$15.67
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.